DBS: Lowering the target price of BYD Electronics (00285.HK) to HK$34, the automotive electronics business is on an upward trend
According to a research report released by DBS, the target price of BYD Electronics (00285.HK) was reduced from HK$38 to HK$34, which is equivalent to 14 times the predicted price-earnings ratio. This is the historical average. The profit forecast for this year and next two years was lowered by 9% and 3% to reflect the pressure on gross profit due to increased smartphone contributions.
Express News | Hong Kong's Hang Seng Index closed up 2.5%, while the Hang Seng Technology Index closed up 4.45%. Shangtang closed up about 36%, NIO Auto closed up about 21%, Country Garden Service closed up about 13%, and Ali Health rose 11%.
Sihuan Pharmaceutical Unit's Lung Cancer Drug NDA Accepted by NMPA, Stocks Shoot Over 10%
Sihuan Pharmaceutical Holdings Group (HKG:0460) said its New Drug Application (NDA) to China's National Medical Products Administration (NMPA) was accepted for the lung cancer drug Dexitinib tablets,
Hong Kong stocks started “booming” in May! The Hang Seng Index reclaimed the 18,000 mark, and in April, Demon Stock added another 30% assist
On May 2, Hong Kong stocks ushered in the first trading day of May, and the three major stock indexes continued their major counterattack!
Most of the Hong Kong Apple concept stocks rose higher. Qiu Titanium Technology rose more than 10%, Shunyu Optical Technology rose more than 4%, and BYD Electronics rose more than 1%.
Most of the Hong Kong Apple concept stocks rose higher. Qiu Titanium Technology rose more than 10%, Shunyu Optical Technology rose more than 4%, and BYD Electronics rose more than 1%.
Changes in Hong Kong stocks | Cornerstone Pharmaceutical-B (02616) rose more than 26%, leading the innovative drug concept, ASCO catalyzes market conditions, institutions are optimistic about policy+health insurance marginal improvement
Zhitong Finance App learned that innovative drug concept stocks showed strong performance. As of press release, Cornerstone Pharmaceutical-B (02616) rose 26.14% to HK$1.11; Cansino Biotech (06185) rose 16.91% to HK$20.95; Gacos-B (01167) rose 14.2% to HK$1.93; Nuocheng Jianhua (09969) rose 12.31% to HK$5.2; Rongchang Biotech (09995) rose 10.2% to HK$30.8. According to the news, the research title of the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was on April 25